Table 1. Estrogen Receptor Binding Assay.
a. Structure and Binding Affinity of Basic TAE, CF, and BN Systems | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Triarylethylene (TAE) |
Cyclofenil (CN) |
Bicyclononane (BN) |
||||||||||
R | lignad | RBAa ERα |
RBAa ERβ |
β/αb | lignad | RBAa ERα |
RBAa ERβ |
β/αb | lignad | RBAa ERα |
RBAa ERβ |
β/αb |
TAE | 377 ± 106 | 238 ± 48 | 0.6 | CF, 2 | 68 ± 18 | 334 ± 54 | 4.9 | BN, 3 | 513 ± 17 | 301 ± 54 | 0.6 | |
4c,d | 20.3 ± 6 | 28.3 ± 7 | 1.4 | 42c | 2.1 ± 5 | 11.3 ± 3 | 5.4 | 17c | 17.7 ± 4 | 25.9 ± 5 | 1.5 | |
4’c | 3.6 ± 1 | 4.2 ± 0.6 | 1.2 | -- | -- | -- | -- | -- | -- | -- | -- | |
-- | -- | -- | -- | 44c | 0.63 ± 0.1 | 1.9 ± 0.6 | 3.0 | 15c | 3.6 ± 1 | 3.1 ± 0.3 | 0.9 | |
-- | -- | -- | -- | 43c | 8.2 ± 0.5 | 28.8 ± 3 | 3.5 | 34c | 52.0 ± 6 | 89.1 ± 9 | 1.7 | |
b. The ERα and ERβ binding affinity of other ligands with a bicyclononane core | ||||||||||||
R’ | R | ligand | RBAa ERα | RBAa ERβ | β/αb | |||||||
-H | -OH | 46 | 0.14 ± 0.02 | 0.30 ± 0.06 | 2.1 | |||||||
-O-CH2-CO2H | -O-CH2-CO2H | 12 | 0.26 ± 0.05 | 0.40 ± 0.05 | 1.5 | |||||||
-OH | -O-(CH2)5-CO2Et | 29 | 15.2 | 30.8 | 2.0 | |||||||
-OH | 26c | 7.5 ± 1 | 7.7 ± 0.7 | 1.0 | ||||||||
-OH | -OSO2CF3 | 11 | 4.2 ± 1 | 8.9 ± 0.7 | 2.1 |
Relative binding affinity (RBA) values are determined by competitive radiometric binding assays and are expressed as IC50[estradiol] / IC50[compound] × 100 (RBA, estradiol = 100). In these assays the Kd for estradiol is 0.2 nM for ERα and 0.5 nM for ERβ.
For each value, the β/α ratio is calculated such that the ratio is >1 for compounds having higher affinity on ERβ than on ERα.
Compounds selected for further studies are indicated by a bold underline.
This compound, GW-7604 (4), exists as a mixture of E and Z isomers. See Figure 1.